DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $16,098,000 | -29.3% | 798,544 | +30.8% | 0.00% | -40.0% |
| Q2 2021 | $22,782,000 | -16.6% | 610,454 | -42.9% | 0.01% | -28.6% |
| Q1 2021 | $27,323,000 | +15.0% | 1,068,569 | -1.0% | 0.01% | +16.7% |
| Q4 2020 | $23,767,000 | +88.3% | 1,078,873 | +53.8% | 0.01% | +50.0% |
| Q3 2020 | $12,621,000 | -5.4% | 701,582 | +33.5% | 0.00% | 0.0% |
| Q2 2020 | $13,346,000 | -39.6% | 525,433 | -56.3% | 0.00% | -50.0% |
| Q1 2020 | $22,083,000 | +31.7% | 1,202,107 | +58.0% | 0.01% | +100.0% |
| Q4 2019 | $16,762,000 | +49.1% | 760,878 | -2.8% | 0.00% | +33.3% |
| Q3 2019 | $11,245,000 | -46.5% | 783,017 | -41.3% | 0.00% | -50.0% |
| Q2 2019 | $21,020,000 | +28.8% | 1,334,646 | +19.8% | 0.01% | +20.0% |
| Q1 2019 | $16,316,000 | +23.9% | 1,113,748 | -9.6% | 0.01% | +25.0% |
| Q4 2018 | $13,173,000 | -36.4% | 1,232,262 | -9.2% | 0.00% | -20.0% |
| Q3 2018 | $20,705,000 | +206.3% | 1,356,784 | +145.9% | 0.01% | +150.0% |
| Q2 2018 | $6,759,000 | -10.3% | 551,814 | -30.0% | 0.00% | 0.0% |
| Q1 2018 | $7,539,000 | +329.8% | 788,604 | +306.1% | 0.00% | – |
| Q4 2017 | $1,754,000 | +189.4% | 194,198 | +84.2% | 0.00% | – |
| Q3 2017 | $606,000 | +765.7% | 105,420 | +334.1% | 0.00% | – |
| Q4 2016 | $70,000 | -72.4% | 24,286 | -43.7% | 0.00% | – |
| Q3 2016 | $254,000 | +95.4% | 43,141 | -0.8% | 0.00% | – |
| Q2 2016 | $130,000 | -22.2% | 43,469 | +39.4% | 0.00% | – |
| Q1 2016 | $167,000 | -11.2% | 31,172 | +97.3% | 0.00% | – |
| Q4 2015 | $188,000 | +72.5% | 15,799 | +19.4% | 0.00% | – |
| Q3 2015 | $109,000 | -67.0% | 13,232 | -44.0% | 0.00% | – |
| Q2 2015 | $330,000 | +28.9% | 23,634 | +160.3% | 0.00% | – |
| Q1 2014 | $256,000 | – | 9,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |